Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114276411B reveals a solid-phase method for trisulfide cyclic peptides. Achieve high purity and yield with scalable manufacturing for pharmaceutical intermediates.
Novel liquid-phase side chain synthesis reduces costs and improves purity for Tirzepatide manufacturing, offering significant supply chain advantages for global pharmaceutical partners.
Patent CN119661412A reveals a high-yield synthesis route for Upadacitinib intermediates, offering significant cost reduction and scalable manufacturing solutions for global supply chains.
Patent CN103539702A reveals a greener route for N'-aryl-N,N-dimethylformamidine synthesis, enabling cost reduction in API manufacturing for oncology drugs like Erlotinib.
Patent CN110105293B details a visible-light driven method for synthesizing C-3 difluoromethyl quinoxalinones, offering a greener, safer route for pharmaceutical intermediate manufacturing.
Patent CN110698474B reveals a mild, one-pot synthesis route for alpha-substituted tetrahydro-gamma-carbolines, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel method for synthesizing intramolecular thioether impurities of sugammadex sodium using mild conditions. Enhances quality control and supply chain stability for API manufacturers.
Patent CN101914030B reveals a high-yield route for 13C 15N glycine using bromoacetic acid and hexamethylenetetramine, ensuring >99% isotopic purity.
Patent CN103183612A reveals a homogeneous alkylation method for dipropylmalonic acid diester, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104876995B details a 5-step Swern oxidation route for 6ECDCA. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Advanced synthesis of emodin quaternary phosphonium salts via Williamson etherification. Enhanced anticancer activity and scalable pharmaceutical intermediate manufacturing solutions.
Novel copper-catalyzed method for 2-phenylthiobenzoic acid production. High yield, scalable, eco-friendly pharmaceutical intermediate supply chain solution for global buyers.
Patent CN109456300B reveals a novel oxidation method reducing impurities below 0.05%, ensuring reliable supply and cost reduction in API manufacturing.
Patent CN116947650A reveals a novel decarboxylation route for cyclopropylamine. Discover cost reduction in pharmaceutical intermediates manufacturing and high-purity production capabilities.
Novel one-pot method for Avibactam Sodium ensures high purity and safety. Reduces manufacturing complexity for pharmaceutical intermediate supply chains globally.
Patent CN118271376A reveals a novel allyl sulfone glycosyl donor for high-yield thioglycoside synthesis. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN101323614B enables zero discharge folic acid manufacturing with higher yield and reduced water consumption for sustainable supply chains.
Novel patent CN101153013B offers high-yield DL-tyrosine-15N synthesis process. Ensures supply chain reliability and significant cost reduction for global research teams.
Novel Pd-Cu catalytic synthesis ensures high yield and purity for pharmaceutical intermediates. Reduces costs and enhances supply chain reliability for global buyers.
Patent CN114685558A reveals a high-yield preparation method for Remdesivir intermediate Compound I, offering significant cost reduction and supply chain reliability for global API manufacturers.